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Abstract—Biosurveillance, a relatively young field, has recent-
ly increased in importance because of its relevance to national 
security and global health. Databases and tools describing par-
ticular subsets of disease are becoming increasingly common in 
the field. However, a common method to describe those diseases 
is lacking. Here, we present the Anthology of Biosurveillance 
Diseases (ABD), an ontology of infectious diseases of biosurveil-
lance relevance. 
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I. INTRODUCTION 
Biosurveillance is a relatively young field. While the first 
health surveillance systems are from the fourteenth and 
fifteenth centuries during the Black Death (a large outbreak of 
pneumonic plague) [1], health surveillance was only 
recognized as its own field in the 1960s [1], and the U.S’ first 
national strategy for biosurveillance was released only in 2012 
[2]. Further, this discipline is broad in nature. The national 
strategy for biosurveillance calls for systems to “detect, track, 
investigate, and navigate incidents affecting human, animal, 
and plant health, thereby better protecting the safety, well-
being, and security of the American people” [2], but 
biosurveillance often falls under global health security [3]. 
Because of the breadth that human, plant and animal health 
encompasses, only recently has there begun to be consensus in 
the field about what the full “biosurveillance” spectrum is, 
what data streams are included in such surveillance [4], and 
further, what diseases are relevant. 
Los Alamos National Laboratory provided one of the first 
comprehensive analyses of biosurveillance goals and data 
streams and used that analysis to implement the 
Biosurveillance Resource Directory (BRD) [4]. During 
development of this database, it became clear that appropriate 
description of biosurveillance resources required an 
unambiguous description of relevant diseases. However, 
existing diesease ontologies describe particular populations 
(e.g. animals, but not humans, or visa versa), and tend to rely 
on clinical characteristics that may or may not be applicable to 
systems sureying various global domains (e.g. plants) or using 
methods that avoid clinical diagnosis of disease. To that end, 
we developed a globally applicable ontology for 
biosurveillance application named the “Anthology of 
Biosurveillance Diseases” (ABD). 
II. ONTOLOGY DEVELOPMENT 
A. Logistic Ontology Requirements 
It is important that the developed ontology meet the 
following requirements: 
• Correctly identify diseases from synonyms: “German 
measles”, for example, is not a term for measles, but 
rather for the disease rubella. Similarly, “rubeola” 
refers not to rubella, but to measles [5]. It was vital to 
ensure that our ontology capture these synonyms, and 
others like them, without confusion. 
• Describe organisms associated with diseases, either by 
causing a disease, spreading a disease, or being 
infected with a disease at varying levels of resolution: 
Some diseases, such as dengue and chikungunya, are 
spread by specific vectors, in this case Aedes aegypti 
and  Aedes albopictus [6]. Other diseases, for example, 
avian pox, are transmitted by “mosquitos” more 
generally [7]. All related organism information, even 
associations at varying levels of resolution, need to be 
clearly described in the ontology. 
• Flag items of biosurveillance relevance to particular 
sub-fields: Within biosurveillance, resources focus on 
paritcular subsets of disease. Some, for example focus 
on bioterrorism (e.g., BioALIRT [8]), while others 
focus on reportable diseases (e.g., 122 Cities Mortality 
Reporting System [9]). In order to maximize utility, we 
wanted to be able to aggregate diseases that fell under 
particular categories, as well as diseases that fell within 
multiple categories. Specifically, we were interested in 
bioterrorism diseases, diseases of economic 
importance, US reportable diseases, vaccine-
preventable diseases, zoonotic diseases, drug resistant 
diseases, and emerging or re-emerging diseases. 
However, we also wanted to be able to broaden the 
scope in the future if needed. 
• Specify disease information in varying levels of detail: 
Much of biosurveillance takes place under an umbrella 
of syndromic surveillance [9]. Such systems look for 
particular clinical symptoms, or syndromes, rather than 
for confirmed diagnosis of particular diseases. Thus, it 
was also important that we be able to 1) represent 
syndromes in the same fashion as diseases and 2) 
understand the links between syndromes and diseases. 
• Be extensible: It became clear early on that any 
ontology for biosurveillance would need to be easily 
extensible to other data, and potentially to other 
languages. For example, it is unlikely that our ontology 
would be comprehensive enough to meet all 
biosurveillance needs. Thus, the goal was to provide a 
framework that was simple and useful enough to 
extend in other directions as it became necessary. We 
also noted that, while our team works exclusively in 
English, many in the field of biosurveillance do not. 
Further, disease names and synonyms change with 
language. It was important that the ontology we 
designed be able to extend to other languages for this 
reason. 
• Be transparent: Because information about some 
diseases may be contested (e.g., can Zika be sexually 
transmitted?), it is imperative that all source 
documentation be explicit such that users could verify 
where information came from. 
B. Technical Ontology Requirements 
• Be easily applied within current biosurveillance tools 
in different formats (e.g. JSON, OWL): While OWL is 
commonly used among ontologists, biosurveillance 
tools are not typically designed to accept such formats. 
We wanted to design our ontology in a fashion that 
would allow export to multiple formats, such that the 
ontology could be easily applied in different scenarios.  
• Searchable via API: Related to the above, it was also 
necessary that internet applications, like those that are 
common in biosurveillance, have an easy mechanism 
for use of the ontology. One such mechanism would 
be an Application Program Interface (API). API’s al-
low other programs to retrieve database results in a 
simple, computer-readable format. This allows for 
easy interactions between databases, or between data-
bases and online tools.  
C. Survey of Current Disease Ontologies 
Prior to building our own ontology we surveyed existing 
ontologies and found two related to disease: 
• Human Disease Ontology/ Disease Ontology: This 
ontology was developed as part of the NuGene project 
and approaches disease ontology from a human, diag-
nostic perspective [11-12]. Fields focus on anatomy 
and tissue level processes/ effects of the disease.  
• Infectious Disease Ontology: This ontology describes 
infectious diseases but places emphasis on clinical/ la-
boratory components [13-14]. This emphasis conflicts 
with our need for both high resolution and generic 
syndromic categories. This ontology incorporates data 
from numerous other ontologies including the Human 
Disease Ontology [14]. 
In order to understand if these ontologies fit our needs we 
compared them to the ontology requirements described in IIA. 
Results of this analysis are given in Table 1.  
 
Requirements 
Disease Ontology 
Human Disease 
Ontology [11-12] 
Infectious Disease 
Ontology [13-14] 
Synonyms Yes No 
Agents, vectors, & 
populations asso-
ciated with diseas-
es described 
Only human diseas-
es are described. Yes 
Disease properties 
flagged 
Some properties are 
flagged, but none 
are biosurveillance 
related 
Some properties are 
flagged. A few (e.g. 
drug resistance) 
overlap with our 
categories of interest. 
Disease hierarchy 
& Syndromic 
disease categories 
Syndromes don’t 
correspond to 
syndromic biosur-
veillance. 
A hierarchy exists, 
but there are no 
syndromic categories 
Extensible formats Only OWL or OBO Only OWL or OBO 
Table 1: The Human Disease Ontology and the Infectious Disease Ontol-
ogy are compared with respect to the specific needs of a biosurveillance 
ontology. Requirements on the right are abbreviations of the bullet points 
within IIA. While both ontologies meet some requires, neither meets all. 
 
The two existing ontologies departed substantially from 
the comparatively simple description of diseases and relations 
required for biosurveillance. Neither provided needed proper-
ties, syndromes, or a disease hierarchy relevant to biosurveil-
lance. Further, neither was available in a format that was easi-
ly “plugged in” to our existing biosurveillance tools. We 
therefore began development of a biosurveillance relevant 
ontology. 
 
III. ONTOLOGY STRUCTURE 
A. Definitions 
The following definitions were used to describe ontology 
fields: 
• Agent: This is the causative agent or organism of the 
disease. For example, Plasmodium vivax is a causative 
agent of malaria. 
• Population: This is the population the disease affects. 
For example, malaria affects humans.  
• Disease synonym: These are names referring to the 
same disease. For example, malaria is sometimes re-
ferred to as “Malignant tertian fever”. 
• Vector: This is an organism that helps transmit the 
disease. It is only present in vector-borne diseases. In 
the case of malaria, the vector is the Anopheles mos-
quito. 
 • Property: These are flags of biosurveillance rele-
vance. Malaria is flagged as drug resistant, emerging 
or re-emerging and US notifiable disease. 
• Transmission: This is the mechanism for transmission 
of the disease from one population member to another. 
Options are binned into air-borne, casual contact, fom-
ite, ingestion, in-utero, sexual transmission, vector-
borne and water-borne. 
• Disease parent: The hierarchical disease parent of a 
child. Malaria, for example, is a child of the syndrome 
‘respiratory diseases’.  
B. Schema 
The current schema of our ontology is in Figure 1. 
Fig. 1. Entity relationship diagram for Anthology of Biosurveillance 
Diseases  Disease has 6 main descriptors: agent, population, vector, property, 
tranmsission and document. Organisms (agents, populations and vectors) are 
described by common and scientific names and include a heirarchical 
component. Transmission and property are catgorical lists with relevant terms 
and associated descriptions. Document describes source information. Diseases 
are described by their 6 components as well as through their disease 
heirarchy. 
We used the following methods to address each 
requirement established above:  
• Correctly identify diseases from synonyms: Synonyms 
were curated manually starting with a the base set of 
synonyms identified by our collaborators at Digital 
Infuzion, Inc. They started with U.S. notifiable 
diseases and the human disease subset of Disease 
Ontology. Synonyms were identified using WordNet 
[15]. Our team then verified and expanded the disease 
and synonym lists through literature reviews.  
• Describe disease agents, disease vectors, and 
populations affected by disease at varying levels of 
resolution: All components associated with the 
organism table have their own fields and heirarchy (see 
figure 2). Within the organism table we specify parent 
organisms (parents are heirarchical relationship 
allowing us to specify that “Anopheles” is a child of 
“Mosquito”), common name, synonyms, and scientific 
name. This enables the user to find all diseases that 
meet criteria at varying levels of resolution. For 
example, in the user interface, a user can search for 
diseases that are spread by “insects”, “mosquitos”, or 
“Anopheles” specifically. This capability is currently 
being added to the API. Wherever possible we include 
the highest resolution reported in literature. In many 
cases this is species, strain, or serotype information. 
• Flag items of biosurveillance relevance (e.g. 
bioterrorism diseases): We selected flags based on 
categories experts in the field were interested in noting. 
They include: select agents and toxins, diseases of 
economic importance, US reportable diseases, vaccine-
preventable diseases, zoonotic diseases, drug resistant 
diseases, and emerging or re-emerging diseases. 
• Specify disease information in varying levels of detail: 
Just as organisms have self referencing ties allowing a 
heirarchy, diseases also have parents. Our disease 
heirarchy has two components. The first is that some 
clinical diseases are parents of other diseases. For 
example, influenza is a parent of avian influenza. The 
second is that diseases also fall into syndromic 
categories that are treated like diseases, but are flagged 
as syndromes. Influenza, in this case, is also a child of 
“respiratory diseases”. The parent to child relationship 
is a many-to-many one, meaning that diseases can be  
the children of multiple parents, and visa versa. We 
believe that this is a very important component of our 
ontology, because it allows for broader specification of 
disease than a heirarchy without this component. 
 We found that, while there are a variety of 
schemas for describing syndromic disease groups at a 
high level, there is substantial overlap between them. 
For the purposes of this ontology we used a 
modification of the CDC’s Essence II categories [16]. 
Specificially, we use: respiratory, gastrointestinal, 
febrile, hemorrhagic, dermatologic, and nervous 
system.  
• Be extensible: The ontology was originally designed as 
part of a SQL database. This allows for exceptionally 
easy addition of new information. For example, we are 
currently planning to extend the ontology to include 
relevant ICD-9 and ICD-10 codes. Because of the back 
end structure, this is a relatively simple process 
whereby we design a table, connect that table to the 
disease ontology and add the relevant information. 
Once this is done, the resulting information is added to 
the API and can be exported to other formats (e.g., 
RDF/XML).  
• Be easily applied within current biosurveillance tools 
in different formats (e.g. JSON, OWL): The ontology is 
a SQL database with a Django application overlay. We 
implemented a REST API using Django’s REST API 
framework that allows users to query the ontology 
database and export to JSON and XML [17]. Further, 
we designed an export of the database to RDF/XML 
compatible with OWL, the format currently utilized by 
ontologists. This allows computationally experienced 
users to export in JSON or XML. Our own 
 biosurveillance tools take advantage of the database 
and the API, while other users can take advantage of 
other formats (e.g., RDF/XML), as needed.  
• Be transparent: All references to literature are 
documented in the database through links to the 
documents table (see figure 1). Of note, references are 
not currently included in exports, or as part of the API. 
This feature will be added. 
An example of the ontology applied to malaria is given in 
figure 2. Relationships between organism, agent, population, 
vector and associations to disease are described, as well as 
relationships between disease and disease syndrome, and 
disease and properties/ transmission. 
Fig. 2. Ontology malaria description Documents have been omitted and 
some organism associations were truncated for brevity. Both organisms and 
diseases have heirarchy elements, allowing for optimal searching and more 
complete disease descriptions. Diseases are described by associated 
synonyms, properties and transmission.  
IV. FUTURE DIRECTIONS 
A. Applying the ontology to biosurveillance 
Using this ontology we have associated specific diseases, 
or types of diseases, with relevant biosurveillance resources 
and disease models in the Biosurveillance Resource Directory 
[18-19]. Additional work of this nature will allow us to facili-
tate more precise communication between biosurveillance 
tools currently in development, as well as find and fix flaws in 
our ontology. 
B. Ontology availability 
There is a user interface for the ontology available at: 
http://brd.bsvgateway.org/disease/ 
The API is available at: http://brd.bsvgateway.org/api/ 
The RDF/XML specific export is available at: 
http://brd.bsvgateway.org/disease.owlrdf.xml 
These URLs may change slightly as our websites grow. 
C. People power vs. computer power 
The current process for developing this ontology relies 
substantially on manual curation by a team of biologists and 
public health experts. That has allowed us to put a level of 
detail into the ontology that we believe is beneficial. However, 
we also recognize the substantial number of hours required to 
maintain the ontology. We are interested in insights into ways 
some of this process can be automated. 
D. Next steps 
There are some additional features noted above that we 
hope to add soon: addition of documentation tables to the API, 
and improvement of API query capabilities. Additional next 
steps include the set up of a repository for version tracking 
and to allow outside contributors to make suggestions for con-
tent. We believe a community effort for the maintenance of 
this tool will improve the content and breadth overall. 
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